Eurobiofilms 2022: A translational perspective of biofilm-related persistent infections
- PMID: 39011151
- PMCID: PMC11247261
- DOI: 10.1016/j.bioflm.2023.100168
Eurobiofilms 2022: A translational perspective of biofilm-related persistent infections
References
-
- Laulund A.S., Schwartz F.A., Christophersen L., Kolpen M., Østrup Jensen P., Calum H., Høiby N., Thomsen K., Moser C. Hyperbaric oxygen therapy augments ciprofloxacin effect against Pseudomonas aeruginosa biofilm infected chronic wounds in a mouse model. Biofilms. 2022;5 doi: 10.1016/j.bioflm.2022.100100. - DOI - PMC - PubMed
-
- Lamret F., Lemaire A., Lagoutte M., Varin-Simon J., Abraham L., Colin M., Braux J., Velard F., Gangloff S.C., Reffuveille F. Approaching prosthesis infection environment: development of an innovative in vitro Staphylococcus aureus biofilm model. Biofilms. 2023;5 doi: 10.1016/j.bioflm.2023.100120. - DOI - PMC - PubMed
-
- Baz A., Bakri A., Butcher M., Short B., Ghimire B., Gaur N., Jenkins T., Short R.D., Riggio M., Williams C., Ramage G., Brown J.L. Staphylococcus aureus strains exhibit heterogenous tolerance to direct cold atmospheric plasma therapy. Biofilms. 2023;5 doi: 10.1016/j.bioflm.2023.100123. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources